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Suppression of tubular anion transport by an inhibitor of serum
protein binding in uremia
THOMAS A. DEPNER
Section of Nephrology, Department of Medicine, University of California. Davis, School of Medicine, Sacramento, California
Suppression of tubular anion transport by an inhibitor of serum protein
binding in uremia. Extraction of acidified uremic serum yields an
inhibitor of phenytoin binding to normal serum proteins and improves
binding to the uremic serum proteins. The extract contains binding
inhibitors (In) that may accumulate because of poor renal excretion and
that are presumed to compete for binding sites on albumin, the principle
binding protein in serum. If substantially bound to protein, the normal
mode of excretion maybe via tubular secretion. In this study, individual
extracts from six stable hemodialyzed patients caused significant inhibi-
tion of para-aminohippurate (PAH) uptake by rat kidney slices incubat-
ed in vitro. During a 90-mm incubation, slice-to-medium ratios fell in a
curvilinear dose-related pattern to 29.8% (sEM) 3.6% (N = 6) cf
control values, compared with 56.4% 2.1% after incubation with a
similar extract from six normal serum samples. The dose-response
curve is similar to that of a known competitive inhibitor, hippuric acid,
and the average inhibitory activity of uremic extract as derived from
these curves was 3.5 times that of an extract from six normal controls.
The effect was easily reversed by washing the slices in medium
containing no inhibitor. Whole serum from these same patients had no
effect on PAH uptake. These findings suggest that I, or other constitu-
ents of the extract may compete for the organic acid secretory pathway
in the proximal nephron. A correlation was seen between inhibition of
phenytoin binding to plasma protein and inhibition of PAH transport in
the slice. Both factors were only partially removed after prolonged
dialysis in vitro, suggesting substantial protein binding. Despite the
clinical stability of these hemodialyzed patients, their serum samples
contain unidentified inhibitors of ligand binding to plasma proteins and
of organic anion transport that share some physiochemical properties.
Suppression du transport tubulaire d'anions par un inhibiteur de Ia
liaison aux protéines sériques dans l'urémie. L'extraction de serum
urémique acidiflé permet d'obtenir un inhibiteur de La liaison aux
protéines sériques urémiques est augmentee. L'extrait contient des
inhibiteurs de liaison (Ix) qui peuvent s'accumuler en raison de Ia faible
excretion rénale et qui sont présumCs pouvoir entrer en competition
pour les sites de liaison de l'albumine, Ia principale protéine de liaison
du serum. Si Ia liaison protCique est importante Ic mode normal
d'excrétion peut Ctre Ia sécrétion tubulaire. Dans cette étude des
extraits individuels de six malades stables en hemodialyse ont deter-
mine une inhibition significative de Ia captation de para-aminohippurate
(PAH) par des tranches de rein de rat incubées in vitro. Au cours d'une
incubation de 90 minutes, Ic rapport tranche sur milieu diminue selon
une fonction curviligne de Ia dose jusqu'h 29,8% (sEM) 3,6% (N = 6)
des valeurs contrôles, a 56,4% 2,1% après incubation dans un extrait
obtenu a partir de six serums normaux. La courbe dose réponse est
semblable a celle d'un inhibiteur competitif connu, l'acide hippurique,
et I'activité inhibitrice moyenne de I'extrait uremique calculée a partir
de ces courbes est 3,5 fois celle de I'extrait des six serums contrOles.
L'effet est facilement reversible par Ic lavage des tranches dans Un
milieu ne contenant pas d'inhibiteur. Le serum entier de ces méme:;
malades n'a pas d'effet sur Ia captation du PAH. Ces constatations
suggérent que I, ou d'autres constituants de I'extrait peuvent êtrc
compétiteurs pour Ia voie de secretion des acides organiques dans Ic
nCphron proximal. Une correlation a été observée entre l'inhibition de
Ia liaison de Ia phenytoine aux proteines plasmatiques et l'inhibition du
transport du PAH dans les tranches. Les deux facteurs sont seulement
partiellement soustraits après une dialyse prolongee in vitro, ce qui
suggere une liaison proteique substantielle. Malgré Ia stabilité clnique
de ces malades en hemodialyse leurs serums contiennent des inhibiteurs
non identifies de Ia liaison de certains ligands aux protéines plasma-
tiques et du transport des acides organiques qui ont en commun
certaines propriétés physicochimiques.
Recent studies have provided evidence for the accumulation
of unidentified protein-bound ligand(s) to account for the well-
known impairment, in patients with uremia', of protein binding
by plasma to an increasing number of small solutes [1—4]. Thus,
binding of phenytoin, tryptophan, salicylate, and other drugs
can be returned to near normal by treatment of plasma with
charcoal or polymeric resin at pH 3. A crude eluate from resin
that has been so treated impairs binding of phenytoin and
tryptophan to normal plasma [5]. An in vitro assay has been
developed to detect this essential property and is based on
measurement of binding impairment induced in normal plasma
by an unknown substance. Through use of this assay technique,
a number of properties of the impure extract have been demon-
strated. In the free (unbound) state, the binding inhibitor U) is
heat-stable, dialyzes easily across cellophane, and shows a
steep increase in its partition coefficient as the pH falls from 5 to
4 [51.
The latter property indicated the presence of an acidic moiety
and suggests that I, may be one or more of a large number of
organic acids known to accumulate in patients with advanced
renal failure [6,71. This suggestion is also consistent with the
observation that many if not most of the drugs and other
substances that normally bind to plasma proteins are acidic in
nature [8]. Because organic acids, including many of those
'The term uremia or uremic is used in its broad sense to include all
patients with advanced renal failure regardless of symptoms or dialysis
therapy.
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found in the plasma of uremic subjects, are highly concentrated
in normal urine [9], their accumulation in uremic plasma is
presumed to result from failure of excretion. If protein binding
is substantial, filtration would be minimal, and excretion would
likely occur via tubular secretion. The combined effects of
substantial protein binding and vigorous tubular secretion
would lead to clearances of the free (and potentially toxic)
substance that, paradoxically, are higher than renal blood flow.
Thus, the importance of the tubular secretory mechanism for
elimination of unidentified toxic anions originally postulated by
Pitts [101 might be enhanced by protein binding.
To test the above hypothetical schema, we determined the
effect of the crude extract from uremic serum upon renal
tubular transport of an organic acid (para-aminohippuric acid)
and an organic base ('4C-N-methylnicotinamide), using the
well-established rat cortical slice technique [II]. With the same
slice technique, a comparison is made with the effects of whole
serum, ultrafiltrate of whole serum, and a known competitive
inhibitor of organic acid transport.
Methods
Patient and control samples. The subjects for study were
selected from a large population of patients with end-stage renal
disease maintained with hemodialysis from I to 4 years. Selec-
tion was based solely on the intake of few or no drugs and
informed consent. Etiologies for renal failure were varied:
diabetic nephropathy, hypertensive glomeruloscierosis, chronic
glomerulonephritis, and unknown. All patients, as well as age
and sex-matched controls, were fasting for 12 hours and had not
taken caffeine, cigarettes, or medications, including vitamins,
for 12 hours and in most cases 24 hours prior to blood sampling.
Blood was drawn by standard venipuncture via the antecubital
vein or arteriovenous fistula prior to hemodialysis. After clot-
ting at 4° C, serum was separated and stored at —70° C. All sera
were extracted within 6 days of sampling, Large quantities of
exudative pleural fluid were obtained from a single hemodia-
lyzed subject on two separate occasions and stored at —70° C.
Total protein concentration in the pleural fluid was 5.6 g/dl;
albumin concentration was 3.0 g/dl.
Extraction of protein binding inhibitor (13 from serum or
pleural fluid. The preparative technique for adsorption of
acidified plasma to a polystyrene divinyl benzene copolymer
(XAD-2, Biobeads®, Bio-Rad Laboratories, Richmond, Califor-
nia) and subsequent desorption of the polymer with alcohol
have been described [5]. Minor variations include the use of
serum instead of plasma and the use of methanol for elution in
place of ethanol. in brief, 10 ml of serum from each patient and
control were slowly acidified to a pH of 3 with 3 N hydrochloric
acid in 15-mi glass centrifuge tubes. This resulted in a dilution of
3 to 5% of the original serum volume, One milliliter of
prewashed XAD-2 resin was added and mixed for 60 mm. The
resin was then separated and washed five times with 5 ml of
distilled water until no precipitate formed in the wash after
addition of 50% trichloroacetic acid (TCA). Previous studies
could detect little or no binding inhibitory activity in these
water washes. The polymer was then washed two times with 5
ml of methanol using agitation for 60 mm per wash. These
washes were combined and evaporated under vacuum to dry-
ness in a rotary evaporator using 50-mi flasks at room tempera-
ture. The residue was reconstituted in I .0 ml of Cross-Taggart
salt solution (CTM, see below) without PAH or other sub-
strates. The efficiency of removal of transport inhibitor for a
single extraction was determined by repeated extractions of the
same serum and found to be approximately 75%. Large vol-
umes of extract were obtained from uremic pleural fluid in a
similar manner by increasing the scale of preparation. Limited
studies of this pleural fluid extract find it in all respects
indistinguishable from uremic serum or plasma extract.
Assessment of protein binding inhibition by L. Our previous
studies demonstrated a significant enhancement of assay sensi-
tivity to I when plasma is diluted with buffered salt solution or
water [5]. Normal (test) plasma samples obtained from fasting
volunteers was diluted with distilled water at a plasma-to-water
ratio of 1:8. '4C-phenytoin (specific activity, 49.4 mCi/mM;
from New England Nuclear, Boston, Massachusetts) was then
added to a final activity of 0.05 Ci/ml, and sodium phenytoin
was added to a final concentration of 0.06 m. To 1.25 ml of
this diluted plasma, 0.1 ml of l (or CTM control) prepared as
above was added, mixed, and allowed to stand at 4° C over-
night. The mixture was then transferred to cellophane bags and
binding assayed by centrifugal ultrafiltration as previously
described [31. Percent unbound is calculated as cpm per millili-
ter of filtrate divided by cpm per milliliter of plasma. The
percent bound equals 100 minus the percent unbound. Control
binding for the diluted plasma averaged 50.1%. Results are
expressed as a difference between percent of '4C-phenytoin
bound in the presence and absence of I. Provided the decrease
in binding does not exceed 30%, the decrement in binding
observed after addition of I, is linearly related to the amount of
inhibitor present [5].
Assessment of organic acid and base transport inhibition
(activity) by 1. and hippurate. Renal cortical slices from male
Sprague-Dawley rats (200 to 250 g) were prepared by free-hand
slicing as described by Hook and Munro [121, Slice thickness
was determined from tissue weight and area measured by
planimetry. Approximately 100 mg of slices 0.15 to 0.2 mm in
thickness were placed into 30-mi beakers containing 3.0 ml of
salt solution described by Cross and Taggart [II]. To this
medium, which contains 7.4 x l0 M PAH, was added '4C-N-
methylnicotinamide (14C-NMN) (specific activity, 2.6 mCi/mM;
from California Bionuclear, Sun Valley, California), 7.0 x 10_6
M, 0.02 Ci/ml.
Sodium hippurate (Sigma Chemical Company, St. Louis,
Missouri) was diluted with CTM to achieve final concentrations
of 0.02, 0.05, and 0.10 m in the medium. The maximum
volume of serum, hippurate, serum extract (lx) or serum
ultrafiltrate added to each 3.0-mI beaker was 0.3 ml. Control
beakers for study of I,, or hippurate received 0.3 ml of CTM
which contained no PAH. Controls for study of serum or
ultrafiltrate of serum received 0.3 ml of normal saline. Where
less extract is added (for dose-response studies) additional
medium was added to bring the volume of additive to 0.3 ml.
Thus all beakers contained a total volume of 3.3 ml. The pH of
media, after addition of I, was measured with a Fisher Accu-
met Model 520 digital pH meter using a combination electrode.
The beakers were incubated at 25° C for 90 mm. under 100%
oxygen in a Dubnoff metabolic shaker, After incubation, slices
were removed, blotted, weighed and immediately transferred to
15-mi centrifuge tubes containing 3.0 ml of 10% TCA. The
tissue samples were then ground for I to 2 seconds with a high
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speed rotary grinder (Polytron®, Brinkman Instruments, New
York) and diluted to 10 ml with distilled water. Two-milliliter
samples of each medium as well as the original medium were
likewise added to 3.0 ml of 10% TCA and diluted to 10 ml
without grinding. All tubes were then centrifuged at >< 1 ,200g for
20 mm. PAH concentrations in the supernatants were measured
by Bratton and Marshall's technique for detection of sulfanil-
amide as modified by Smith [13, 14]. Duplicate 0.5-mi aliquots
of the supernatant were assayed for '4C-NMN activity with a
liquid scintillation counter (Searle Mark II, Des Plaines, Illi-
nois) using an external standard. Slice-to-medium (S/M) ratios
are expressed as the concentration of PAH or '4C-NMN per
gram (wet wt) of tissue divided by the concentration in the
medium.
In vitro dialysis. Ten milliliters of uremic pleural fluid was
dialyzed in prewashed 7A-inch seamless cellulose tubing (GK
Besonson Co., Flushing, Michigan) at 4° C for 24 hours against
5.0 liters of 0.30 mrvi Tris buffered salt solution (sodium 116,
potassium 5, calcium 2.3, magnesium 1.2, chloride 135, sulfate
1.2 mEq/Iiter; pH 7.4 at 5°C), using constant agitation by means
of a dialyzer-agitator (Oxford Laboratories, Foster City, Cali-
fornia). Both dialyzed and undialyzed pleural fluid was then
extracted by the XAD-2 technique described above. Inhibition
of slice uptake of PAH was measured in the presence of 0 to 0.3
ml of the extract by the Bratton-Marshall [11] technique de-
scribed above. Inhibition of phenytoin binding by this extract
was measured using the diluted plasma assay system described
above. Control aliquots of the same pleural fluid were exposed
to cellophane at 4° C without dialysis for 24 hours. Creatinine
was measured by the colorimetric alkaline picrate method.
Washout of inhibitor (it). The reversibility of transport
inhibition was tested by first adding the inhibitor to tissue slices
and then attempting to wash it out. This study required three
steps: (I) slices were incubated with oxygen as above in 3.0 ml
Cross-Taggart medium containing 0.3 ml I, (extracted from
pleural fluid) but without substrate for 60 mm. (2) The slices
were then transferred to larger beakers containing 30 ml of
medium without substrate or 1, and incubated under a nitrogen
atmosphere for 30 mm. (3) These same slices were then
transferred to 30-mI beakers containing 3.0 ml of medium with
PAll and '4C-NMN but without inhibitor. Inhibited controls
were treated in a similar manner except that step 2 was omitted
and the final incubation medium (step 3) contained 0.3 ml of 1,.
Uninhibited controls were preincubated for 60 mm in media
without inhibitor or substrate before going to step 3.
Statistical analysis. Means and standard errors are compared
using Student's t test; variances are examined using the Fisher
test and one-way analysis of variance. Regressions are deter-
mined by the method of least squares.
Results
The average SIM ratio for PAH uptake by control slices in the
absence of inhibitor is 13.4 (sEM) 0.37 (N = 61) similar to that
reported by others [II]. Because control uptake was measured
for slices from each kidney, a comparison of intra-rat versus
inter-rat variance is possible. The SD for within-rat S/M ratios
was 0.89 whereas the SD for S/M ratios among control rats was
3.18 (N = 20, P < 0.001). This indicates that differences in
control S/M ratios were for the most part due to rat-to-rat
variation and not to random differences in individual slice or
Subject no.
At
PAH
0 ml
NMN
At 0.05 ml At 0
PAH NMN PAH
.10 ml
NMN
At 0.
PAH
30 ml
NMN
Uremic subjects
1 14.5 5.6 9.8 4.1 8.4 3.7 5.4 2.8
2 13.1 4.9 11.2 4.1 8.1 3.1 4.1 1.9
3 12.2 6.5 7.2 3.8 6.2 3.7 3.3 2.2
4 12.2 6.2 7.8 3.7 8.0 3.9 5.0 2.6
5 18.0 6.8 9.8 5.8 7.4 5.3 2.8 3.4
6 18.5 6.6 13.7 6.3 10.5 5.6 5.0 3.6
Mean 14.8 6.1 9.9 4.6 8.1 4.2 4.3 2.8
Normal subjects
7 16.2 7.3 13.6 5.0 11.7 3.7 8.5 2.6
8 15.8 6.8 13.8 5.7 13.4 5.4 9.2 3.8
9 13.0 7.6 11.3 6.8 10.0 5.5 7.6 4.5
10 12.3 7.6 11.3 6.7 9.3 5.8 6.6 4.5
11 13.3 7.4 10.5 4.8 10.8 5.3 8.6 4.1
12 13.2 6.6 11.0 5.3 9.4 5.1 6.8 3.6
Mean 14.0 7.2 11.9 5.7 10.8 5.1 7.9 3.9
±SEM ±0.7 ±0.2 ±0.6 ±0.4 ±0.6 ±0.3 ±0.4 ±0.3
° The graded doses of serum extract are measured as
extract added to 3 ml of medium.
the amount of
kidney transport. The inter-rat variation is most likely due to
differences in availability of endogenous substrate. Similar data
were obtained for '4C-NMN uptake by control (uninhibited)
slices from each kidney. S/M ratios averaged 6.65 ± (SEM 0.11
(N = 55). The SD for paired kidneys from the same rat was 0.54
whereas the SD for S/M ratios among rats was 0.96 (N = 18, P <
0.02). Whenever possible S/M ratios are expressed as a fraction
of the control ratio to avoid scatter due to the above inter-rat
variation.
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Fig. t. SIM ratios of PAH achieved by rat kidney slices after addition to
the medium (3.0 ml) of 0.3 ml extract of serum from 6 hemodialvzed
(uremic) subjects. These are compared with 6 control S/M ratios in the
absence of added extract. Height of bars represents mean ± SEM.
Table 1. Effect of graded doses of serum extract on PAH and NMN
uptake (S/M ratio) by rat kidney slices°
Fig. 2. Slice uptake ofPAH at varying concentrations of extract from
normal (0) and uremic (•) serum. Data derived from Table I represent
mean SEM, N = 6. ® denotes response to 0.3-rn! "extract" of normal
saline. *D (uremic vs. normal) < 0.01.
Concentration of serum extract, mi/3m/of medium
Fig. 3. Slice uptake of '4C-NMN at va,ying concentrations of extract
from normal (0) and ure,nic (•) serum. Data derived from Table I
represent mean SEM, N = 6. ® denotes response to 0.3-mi "extract"
of normal saline. P.> 0.05 at all doses.
Fig. 4. In verse of SIM ratio plotted against concentration of I,- on
abscissa renders near linear fit to data in Fig. 2. Control slices are
obtained from the same kidney, but are not exposed to inhibitor. Ratio
of uremic (•)/normal (0) slopes approximates the ratio of inhibitory
effect (3.53). The response to hippurate (A---A) is qualitatively similar
to that of the extracts. Data represent mean 5EM.N for hippurate =
15.
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After 90 mm of incubation, recovery of '4C-NMN averaged
102.0 + 0.3% (N = 55), and recovery of '4C-PAH was 102.3
(sEM) 0.65% (N = 17). Recovery of PAR determined by
colorimetric assay, however, was 82.8 (sEM) 1.02% (N = 61).
After 60 mm of heating at 900 C in 1.2 N hydrochloric acid,
recoveries increased to 100,8 (sEM) 1.5% (N = 14). These
data are consistent with previously reported metabolism of
PAH by rat cortical slices to the N-acetyl derivative [15, 161.
S/M ratios for '4C-PAH versus unlabeled PAH after incubation
from 0 to 90 mm were not different, signifying that under the
conditions of these experiments PAH and its metabolites are
perceived as identical by the transport system.
The XAD-2 resin extracts of acidified uremic serum markedly
inhibited the uptake of PAR by renal cortical slices when added
to the medium at a 1:10 volume-to-volume ratio (Fig. 1). The
relationship between volume of extract added and S/M ratio
achieved is not linear, however, so that a significant inhibition
of uptake is seen at 1:60 volume-to-volume ratio (Table I and
Fig. 2). Normal serum extracts were much less potent than
resin extracts from uremic serum were: a significant difference
between the effect of normal versus uremic extract is seen at all
concentrations of I, examined. At the 0.3-mI point, S/M ratios
for the uremic extracts are 29.8% 3.6% of controls whereas
S/M ratios for normal extracts are 56.4% 2.1% of controls.
Only a small and statistically insignificant difference between
the effects of normal and uremic serum extracts is seen for 4C-
NMN uptake by the kidney slices (Fig. 3).
A linear relationship is established for PAH uptake by
plotting medium-to-slice ratio versus amount of added inhibitor
0
0
C.,
C
a,E
a,0.x0)I
0
0
a'
CC
0
E
0a'
0.10 0.20
Concentration of serum extract, mf/3 ml of medium
10 20 30 40
Phenytoin binding decrement, %
Fig. 5. Correlation between effect of I, on drug binding 10 plasma
protein (abscissa) and effect of I, on slice uptake of PA!-! (ordinate).
The open circle (0) denotes extract of normal serum; the closed circle
(•), extract of uremic serum. See Methods for assay techniques.
(Fig. 4), which permits a quantitative comparison of normals to
uremics. The ratio of slopes in Fig. 4 reflects an average of 3.5
times as much inhibitor of PAH transport in hemodialyzed
uremic sera compared with normal sera. The effect of hippur-
ate, a known competitive inhibitor of PAH transport, is qualita-
tively similar to that of the extract.
The assay technique for slice uptake of both PAH and NMN
detects a significant suppressive effect of extract from normal
serum. This contrasts sharply with the effect of whole normal
serum or ultrafiltrate of normal serum, which in low concentra-
tions stimulates uptake of both these species (Fig. 8). These
effects cannot be attributed to pH changes in the medium
induced by I: pH after addition of I,, = 7.36.
Figure 5 shows a significant negative correlation between
S/M ratio observed in the presence of 0.3 ml of I, and
phenytoin-binding inhibition by 0.1 ml of the same extract of
uremic and normal sera. Because the S/M ratio varies inversely
with the degree of transport inhibition, this plot reflects a
positive correlation between plasma binding inhibition and
PAH uptake inhibition in the kidney slices.
Reversibility of the suppressive effect on slice transport of
both PAH and NMN is shown in Fig. 6. Near complete
restoration of PAH uptake occurs after washing for 30 mm in a
large volume of medium containing no I, whereas less com-
plete restoration of '4C-NMN uptake is observed in the same
slices. Control S/M ratios averaged 13.2 for PAH and 5.8 for
'4C-NMN.
Dialysis for 24 hours against an isotonic 30-mmolar Trits
buffer at 40 C caused an incomplete loss of PAH transport
inhibitor (Fig. 7). Exposure to cellophane for this length of time
had no effect. At the same time that creatinine was >99%
removed, the transport inhibitory activity of extracts from
uremic pleural fluid decreased by 60% as reflected by the ratios
of slopes in Fig. 7. Phenytoin binding inhibition by these same
extracts diminished by 40%. Thus, both plasma binding inhibi-
tion and organic acid transport inhibition are seen to slowly
disappear to a similar extent during prolonged in vitro dialysis.
There was no significant correlation between BUN, creati-
nine, bicarbonate, or anion gap and phenytoin binding by
serum, inhibition of phenytoin binding by extract of serum, or
inhibition of slice transport by extract of serum in this small
patient series.
Stimulation of both PAH and NMN uptake by whole normal
serum is shown in Fig. 8. Whole uremic sera and serum
ultrafiltrates obtained from this series of patients have a slight
but insignificant stimulative effect on PAR transport and a
definite stimulative effect upon NMN transport.
Discussion
Uremic plasma contains inhibitors of ligand binding to plasma
proteins that can be extracted by a technique similar to that
used for defatting albumin [17]. The extract so obtained is
devoid of protein, electrolytes, creatinine, urea, uric acid,
cholesterol, and when reconstituted in water it no longer
contains water insoluble fatty acids. When added to normal
plasma the extract inhibits ligand binding to albumin in a
curvilinear dose-related pattern [51. The present study shows
that with the same technique, the extraction of serum from
hemodialyzed patients yields an inhibitor(s) of PAH transport in
rat kidney slices (Fig. I). The dose-response pattern is curvilin-
ear (Fig. 2), similar to that seen for hippurate, a known
competitive inhibitor of organic anion transport in the proximal
nephron. The linear relationship between the inverse of slice-to-
medium ratio and the dose of inhibitor seen in Fig. 4 is
reminiscent of the linear relationship between the inverse of the
initial velocity and the dose of a competitive inhibitor of carrier-
mediated membrane transport [18]. It is important to note,
however, that slice-to-medium ratios are only indirectly related
to initial velocity of transport; therefore, the competitive nature
of anion transport inhibition demonstrated in these siudies
remains to be established. But regardless of the meaning of
these linear transformations, they provide a convenient means
for comparison of the activity of extract from uremic serum to
that obtained from normal serum: a ratio of 3.5:1.0 (Fig. 4). This
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Fig. 6. Uptake of PAH and '4C-NMN by kidney s/ices preincuhated for
60 mm with I, under oxygen (before), then washed for 30 mm under
nitrogen in medium without I, (after). Plotted values represent mean
SEM of four studies.
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Fig. 8. Effect of 0.3 ml of sera and ultrafiltrates of sera from 4 normal
and 6 hemodialyzed subjects on uptake of PAH and 4C-NMN by rat
kidney slices. Plotted values are means SEM. Mean compared to
100%: 5p < 0.01, *P < 0.001.
of added urernic extract was readily reversed by washing
previously exposed tissue in medium containing no inhibitor
(Fig. 5). A similar reversibility of the effect of whole serum has
been reported [23]. Known competitive inhibitors of PAH and
NMN transport, as well as PAH itself, efflux rapidly from slices
under these conditions [221, but it remains possible that non-
competitive inhibitors of transport and/or metabolism would
efflux as well.
Organic acid transport by renal proximal tubules is inhibited
by whole serum or dialysate from uremic patients [231 or
experimental animals [12, 24], but organic cation transport is
unaffected. This inhibition by uremic serum contrasts with the
effect of normal serum, which stimulates transport of both
species [12]. The effect of uremic serum is thought to result
from competition by organic anions for carrier transport sites
on the basolateral membranes of these cells and correlates with
a widened "anion gap" in the electrolyte pattern of patients in
renal failure. Organic as well as inorganic anions have been
shown to accumulate in renal failure [61. This effect is rapidly
diminished by dialysis in vivo, suggesting that relatively small,
easily dialyzed anions are responsible for the inhibition by
whole unextracted serum and contrasts with the poor dialyz-
ability of I,, (Fig. 7) [231. Previous studies of rat kidney slices
and rabbit tubules exposed to whole uremic serum have impli-
cated hippurate or similar compounds as the most likely cause
of uptake inhibition [23, 251. These studies showed that treat-
ment of uremic animals with oral neomycin decreased serum
hippurate levels, as well as the suppressive effect of serum from
these animals on PAH transport by slices exposed to the serum.
But, the levels of hippurate detected in uremic serum were
insufficient to account for the inhibition of transport [251.
compares to an activity ratio of 5:1 for protein binding inhibitor
extracted from another series of urernic and normal patients [5].
'4C-NMN transport, although suppressed by l,, is sup-
pressed to nearly the same degree by extracts of normal serum
(Fig. 3). This means that the uremic sera used in this study
contain no more extractable inhibitors of organic cation trans-
port than do normal sera. The slight difference observed may be
more pronounced and reach levels of significance in patients
who are more uremic. Because aliphatic and aromatic amines
accumulate in body fluids of patients with renal failure [19, 20],
competitive inhibition might be expected for organic cation
transport at the renal tubule. The lack of inhibition observed
here may indicate that cations accumulating in uremia are more
easily dialyzed perhaps by virtue of being less protein bound,
are not extracted by XAD-2 resin, are not transported, are
transported via other pathways in the tubule, or do inhibit, but
the effect is masked by the concomitant accumulation of
stimulants in uremic serum. In the latter case, fractionation of
uremic serum might separate stimulants of transport that are
known to be present in normal serum [211 from inhibitors
accumulating in uremia.
Irreversible damage to proximal tubular cells by toxins
extracted from uremic serum might be responsible for suppres-
sion of organic anion transport by tissue slices. Because this
transport system is complex and critically dependent upon
oxidative metabolism, damage to organelles other then the cell
membrane itself might result in decreased uptake of PAH. Such
irreversible damage can be excluded as a cause of transport
inhibition observed in this study because the suppressive effect
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The stimulative effect of whole normal serum (Fig. 8) is
thought to be due to provision of substrates such as lactate for
oxidative metabolism by the slice [26]. These substrates when
added to the medium devised by Cross and Taggart can nearly
double the S/M ratio at equilibrium [1!]. Preuss et a! [26] have
shown that gel filtration of uremic serum yields several compo-
nents, some that stimulate and others that inhibit PAH trans-
port by rat kidney slices. Whole serum and serum ultrafiltrate
from the present series of patients had no significant effect ott
PAH transport (Fig. 8). Presumably, the amount of an inhibitor
contained in their serum prior to dialysis in vivo is sufficient to
negate the effect of these naturally occurring stimulants but
insufficient to cause net inhibition of PAH uptake. This may be
due to the stable, well-dialyzed clinical status of these patients,
which results in part from selection on the basis of need for few
drugs.
Serum extract (Is) from these same patients, however, con-
tains a potent inhibitor of protein binding to phenytoin and in
addition inhibits PAH uptake by rat kidney slices to a signifi-
cantly greater degree than similar extracts from normal sera
(Figs. I and 4). A rough correlation is shown between the
potency of I>, for inhibition of protein binding and its capacity to
inhibit PAR transport (Fig. 5). This contrasts with the lack of
correlation between the usual indices of severity of renal failure
such as BUN or creatinine and suppression of anion transport
in the slice. Thus, despite the stability of their clinical state,
serum from these patients continues to demonstrate abnormali-
ties of protein binding and contains extractable inhibitors of
both protein binding and organic acid transport.
Further correlation between these two phenomena is evident
when the effect of prolonged in vitro dialysis is examined (Fig.
7). The removal of each inhibitor is incomplete in comparison to
the removal of creatinine, suggesting that the inhibitor(s) is a
large, poorly dialyzed substance or that protein binding is
substantial. Limited studies of in vitro dialysis of the crude
extract favor the latter, because in the absence of plasma
protein, I,, easily dialyzed across cellophane 151. This indirect
evidence suggests that both inhibitors of protein binding and
organic acid transport may be highly protein bound. Further-
more, it suggests that the extracted transport inhibitor differs
from the easily dialyzed transport inhibitor found by others i:n
whole undialyzed uremic serum [23]. This difference in dialyz-
ability may alternatively be explained by saturation of high-
affinity binding sites as the serum level of inhibitor accumulates
to high levels.
It is possible and in fact likely that I represents several
perhaps biochemically related substances. Preliminary attempts
at purification have revealed several components that inhibit
protein binding and that also inhibit PAH transport. It remains
possible, however, that despite the above correlations between
these two activities, the two inhibitors are distinct or belong to
classes of substances with some overlapping characteristics.
Of considerable interest is the suppressive effect of extract
from normal serum for both anion and cation pathways. A]-
though the effect on anion transport was much less than that
seen with uremic extract, the suppressive effect of normal
extract was significant. A similar inhibition by normal extract
was previously observed for protein binding [5]. The net effect
of whole normal serum may be a result of stimulative and
inhibitory influences on tubular transport as is proposed for
uremic serum except that stimulative effects predominate in
normal serum. Extraction by resin absorption at low pH may
separate these two antagonistic elements. A similar explanation
may be invoked to account for the mild inhibition of protein
binding by extract of normal plasma. Some naturally occurring
ligands that enhance the binding of drugs to albumin [27] may be
separated during the extraction procedure. Because in parallel
studies an "extract" of normal saline had no effect on tubular
transport, the inhibitory effect of normal extract is unlikely to
be due to an artifact of the extraction procedure. But, the latter
explanation cannot be entirely ruled out because acidification of
serum to a pH of 3.0 has the potential for introducing new
artifacts. Further studies of purified serum proteins may shed
more light on this question.
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